Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00276471
Status:
COMPLETED
Last Update Posted:
2012-02-02
First Post:
2006-01-12
Brief Title:
Evaluation of the Tantalus System in Type 2 Diabetic Subjects
Sponsor:
MetaCure Limited
Organization:
MetaCure Limited
Study Overview
Official Title:
Evaluation of the Tantalus System in Type 2 Diabetic Subjects
Status:
COMPLETED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Metacure MC PT TAN2005-013 feasibility study is a prospective multi-center study to evaluate the safety and functionality of the TANTALUS System in the treatment of obese T2DM patients and to assess the effect of GCT Glycemic Control Treatment on weight loss and glycemic control
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None